J Stuginski-Barbosa G G R Rodrigues M E Bigal J G Speciali
10.1007/s10194-008-0003-4
J Headache Pain
2008 Feb;9(1):43-5.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/18219443/
Benzothiazoles / administration & dosage Burning Mouth Syndrome / drug therapy Dopamine Agonists / administration & dosage Mouth Mucosa / drug effects Receptors, Dopamine D2 / agonists
Benzothiazoles / administration & dosage Burning Mouth Syndrome / drug therapy Dopamine Agonists / administration & dosage Mouth Mucosa / drug effects Receptors, Dopamine D2 / agonists Case Reports Aged Burning Mouth Syndrome / metabolism Burning Mouth Syndrome / physiopathology Corpus Striatum / drug effects Corpus Striatum / metabolism Corpus Striatum / physiopathology Dopamine / metabolism Dose-Response Relationship, Drug Drug Administration Schedule Drug Resistance / drug effects Drug Resistance / physiology Female Humans Mouth Mucosa / innervation Mouth Mucosa / physiopathology Parkinson Disease / complications Parkinson Disease / drug therapy Parkinson Disease / physiopathology Pramipexole Prospective Studies Receptors, Dopamine D2 / metabolism Restless Legs Syndrome / drug therapy Restless Legs Syndrome / physiopathology Substance Withdrawal Syndrome / physiopathology Treatment Outcome Benzothiazoles Dopamine Agonists Receptors, Dopamine D2 Pramipexole Dopamine
PMC3476177
18219443
Burning mouth syndrome responsive to pramipexol
2008